Share Option AgreementShare Option Agreement • July 31st, 2023 • Portage Biotech Inc. • Crude petroleum & natural gas • Virgin Islands
This Share Option Agreement (this “Agreement”), dated as of the Grant Date, is between Portage Biotech Inc., a corporation formed under the laws of the Territory of the British Virgin Islands (the “Company”), and ____________________ (the “Optionee”).
OFFICE LEASE by and between WALP 57 - 61, LLC (Landlord) and Portage Development Services, Inc. (Tenant) Dated: March 31, 2023Office Lease • July 31st, 2023 • Portage Biotech Inc. • Crude petroleum & natural gas
CLINICAL SERVICES AGREEMENT This CLINICAL SERVICES AGREEMENT (this “ Agreement ”) is made effective as of the date of last signature below (the “ Effective Date ”) by and between Labcorp Drug Development Inc . with a place of business at 10 Moore...Clinical Services Agreement • July 31st, 2023 • Portage Biotech Inc. • Crude petroleum & natural gas
CERTAIN IDENTIFIED INFORMATION, MARKED WITH “[****]”, HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. LICENSE AGREEMENTLicense Agreement • July 31st, 2023 • Portage Biotech Inc. • Crude petroleum & natural gas • New York
This License Agreement (this “Agreement”) is entered into as of October 29, 2019 (the “Agreement Date”), by and between Tarus Therapeutics, Inc., a company formed under the laws of the State of New York, USA, having a place of business at 6A Cove Lane, North Bergen, NJ 07407, USA (“Tarus”) and Impetis Biosciences Limited, a company incorporated in India, having a place of business at 407, The Summit Business Bay, Near WEH Metro Station, Off. Andheri-Kurla Road, Andheri (E), Mumbai 400 093 (“Impetis”). Each of Tarus and Impetis may be referred to as a “Party” and together as the “Parties”.
LICENSE AGREEMENTLicense Agreement • July 31st, 2023 • Portage Biotech Inc. • Crude petroleum & natural gas
This License Agreement (this “Agreement”), dated as of July 1, 2015 (the “Effective Date”), is made by and between iOx Therapeutics Ltd., a company registered in England under number 09430782 and whose registered office is at 5th Floor, Alder Castle, 10 Noble Street, London EC2V 7QJ, United Kingdom (“iOx”), and the Ludwig Institute for Cancer Research Ltd., a non-profit corporation organized under the laws of Switzerland with its registered office at Stadelhoferstrasse 22, 8001 Zurich, Switzerland and an office at 666 Third Avenue, New York, New York 10017, USA (“LICR”). Each of iOx and LICR may be referred to in this Agreement individually as a “Party” and, collectively, as the “Parties”.
SERVICES AGREEMENT THIS SERVICES AGREEMENT (the “ Agreement ”) is effective as of June 1 , 2022 , by and between Portage Development Services Inc . , a Delaware corporation (the “Company”), and Justin Fairchild a resident of the State of Connecticut...Services Agreement This Services Agreement • July 31st, 2023 • Portage Biotech Inc. • Crude petroleum & natural gas
